Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Sutro Biopharma (STRO) Interest & Investment Income (2017 - 2025)

Historic Interest & Investment Income for Sutro Biopharma (STRO) over the last 9 years, with Q3 2025 value amounting to $2.0 million.

  • Sutro Biopharma's Interest & Investment Income fell 9093.7% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year decrease of 8092.47%. This contributed to the annual value of $25.8 million for FY2024, which is 7768.44% up from last year.
  • According to the latest figures from Q3 2025, Sutro Biopharma's Interest & Investment Income is $2.0 million, which was down 9093.7% from $2.5 million recorded in Q2 2025.
  • Sutro Biopharma's Interest & Investment Income's 5-year high stood at $22.2 million during Q3 2024, with a 5-year trough of -$3.6 million in Q4 2021.
  • For the 5-year period, Sutro Biopharma's Interest & Investment Income averaged around $2.2 million, with its median value being $197000.0 (2021).
  • In the last 5 years, Sutro Biopharma's Interest & Investment Income crashed by 265779.82% in 2022 and then surged by 38718.68% in 2024.
  • Sutro Biopharma's Interest & Investment Income (Quarter) stood at -$3.6 million in 2021, then surged by 307.13% to $7.5 million in 2022, then plummeted by 39.18% to $4.6 million in 2023, then tumbled by 119.77% to -$901000.0 in 2024, then surged by 322.97% to $2.0 million in 2025.
  • Its Interest & Investment Income stands at $2.0 million for Q3 2025, versus $2.5 million for Q2 2025 and $3.2 million for Q1 2025.